Get the Stockscreener App
1.33
6.34%
-0.09
After Hours:
1.30
-0.03
-2.26%
Alector Inc stock is traded at $1.33, with a volume of 411.98K.
It is down -6.34% in the last 24 hours and up +10.83% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$1.42
Open:
$1.42
24h Volume:
411.98K
Relative Volume:
0.44
Market Cap:
$132.99M
Revenue:
$100.56M
Net Income/Loss:
$-119.05M
P/E Ratio:
-1.0813
EPS:
-1.23
Net Cash Flow:
$-231.16M
1W Performance:
+7.26%
1M Performance:
+10.83%
6M Performance:
-48.65%
1Y Performance:
-72.97%
1-Day Range:
$1.30
$1.42
1-Week Range:
$1.22
$1.46
52-Week Range:
$0.87
$6.78
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.33 | 130.99M | 100.56M | -119.05M | -231.16M | -1.23 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 40.37M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Alzheimer's Disease Pipeline 2025: MOA and ROA Insights, - openPR.com
BNP Paribas Financial Markets Grows Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Northern Trust Corp Purchases 40,291 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
D. E. Shaw & Co. Inc. Raises Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Deutsche Bank AG Reduces Stake in Alector, Inc. (NASDAQ:ALEC) - Defense World
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target - BioSpace
Sanofi Makes Alzheimer’s Bet With Vigil Buy - insights.citeline.com
Top Penny Stocks To Watch In May 2025 - simplywall.st
What Did We Note About Insider Trading At Alector Inc (NASDAQ: ALEC)? - Stocksregister
Alector, Inc. (NASDAQ:ALEC) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Dimensional Fund Advisors LP Raises Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector at BofA Securities 2025 Healthcare Conference: Strategic Innovations in Brain Disorder Therapies - Investing.com
Alector Reports Increased Loss, Advances Clinical Pipeline - TipRanks
Alector stock price target raised to $10 at H.C. Wainwright By Investing.com - Investing.com South Africa
Alector stock price target raised to $10 at H.C. Wainwright - Investing.com
Alector (ALEC) to Release Quarterly Earnings on Wednesday - Defense World
Alector, Inc. (NASDAQ:ALEC) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.26 - Yahoo Finance
US$5.26That's What Analysts Think Alector, Inc. (NASDAQ:ALEC) Is Worth After These Results - simplywall.st
Alector (ALEC) Maintains Buy Rating as Price Target Increases | - GuruFocus
Alector First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Alector (ALEC) Price Target Raised by H.C. Wainwright | ALEC Sto - GuruFocus
Alector (ALEC) Maintains Buy Rating as Price Target Increases | ALEC Stock News - GuruFocus
Alector (ALEC) Price Target Raised by H.C. Wainwright | ALEC Stock News - GuruFocus
Alector Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Alector Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Alector (ALEC) Reports Q1 Revenue Shortfall, Advances Drug Trials | ALEC Stock News - GuruFocus
Alector reports Q1 EPS (41c), consensus (46c) - TipRanks
Alector Inc Reports Q1 2025 Earnings: EPS Loss of $0.41 Beats Estimates, Revenue Falls Short at $3.7 Million - GuruFocus
Alector, Inc. SEC 10-Q Report - TradingView
Alector to Participate in Upcoming Healthcare Conferences - GlobeNewswire
Alector Sets Stage for Major Healthcare Conference Appearances: BofA and H.C. Wainwright Presentations Coming Up - Stock Titan
Alector, Inc. (NASDAQ:ALEC) Position Raised by Invesco Ltd. - Defense World
Alector Inc (NASDAQ: ALEC) Analysts Expect It Could Climb 71.8% From Current Levels. - Stocksregister
Alector, Inc. (NASDAQ:ALEC) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Alector Inc (ALEC) shows promising results - uspostnews.com
Alector Inc [ALEC] Shares Fall Approximately -76.81% Over the Year - knoxdaily.com
Market Highlights: Alector Inc (ALEC) Ends on a High Note at 1.22 - DWinneX
Alector Inc (ALEC) Stock: A Comprehensive 52-Week Review - investchronicle.com
XTX Topco Ltd Acquires 22,381 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Geode Capital Management LLC Boosts Stake in Alector, Inc. (NASDAQ:ALEC) - Defense World
Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World
Alector Inc (ALEC): A Sitting Duck With -250.88% Upside Potential - Stocksregister
Following a 75% decline over last year, recent gains may please Alector, Inc. (NASDAQ:ALEC) institutional owners - simplywall.st
There is no way Alector Inc (ALEC) can keep these numbers up - Sete News
A Guide To The Risks Of Investing In Alector Inc (ALEC) - knoxdaily.com
ALEC’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
Neogenomics Inc (NEO) Stock’s Detailed Analysis - Marketing Sentinel
Alector Inc (ALEC): What Makes The Stock Good? - Marketing Sentinel
Gentherm Inc Is A Buy Small Cap Stock: Analysts - Marketing Sentinel
Alector, Inc. (NASDAQ:ALEC) Holdings Cut by JPMorgan Chase & Co. - Defense World
Alector concludes enrolment in Phase II trial of Alzheimer’s treatment - Yahoo Finance
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alector Inc Stock (ALEC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rosenthal Arnon | Chief Executive Officer |
Mar 03 '25 |
Sale |
1.47 |
40,330 |
59,176 |
2,466,744 |
| GRASSO MARC | Chief Financial Officer |
Mar 03 '25 |
Sale |
1.47 |
18,091 |
26,547 |
312,560 |
| Romano Gary | Chief Medical Officer |
Mar 03 '25 |
Sale |
1.47 |
16,306 |
23,927 |
332,977 |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):